[1] WHO.Denguecontrol[EB/OL].2017[2018-01-26].http://www.who.int/denguecontrol/en/.
[2] Rodenhuis-Zybert I A, Wilschut J, Smit J M. Dengue virus life cycle: viral and host factors modulating infectivity[J]. Cell Mol Life Sci, 2010, 67(16): 2773-2786.
[3] Wallis T P, Huang C Y, Nimkar S B, et al.Determination of the disulfide bond arrangement of dengue virus NS1 protein[J]. J Biol Chem, 2004, 279(20): 20729-20741.
[4] Pryor M J, Wright P J.Glycosylation mutants of dengue virus NS1 protein[J]. J Gen Virol, 1994, 75(5): 1183-1187.
[5] Chung K M, Liszewski M K, Nybakken G, et al.West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H[J]. Proc Natl Acad Sci USA, 2006, 103(50): 19111-19116.
[6] Liu J, Liu Y, Nie K, et al.Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes:[J]. Nat Microbiol, 2016, 1(9):16087.
[7] Rastogi M, Sharma N, Singh S K.Flavivirus NS1: a multifaceted enigmatic viral protein[J]. Virol J, 2016, 13(1): 131.
[8] Hori H, Lai C J.Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1[J]. J Virol, 1990, 64(9): 4573-4577.
[9] Falgout B, Chanock R, Lai C J.Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a[J]. J Virol, 1989, 63(5): 1852-1860.
[10] Alcalá A C, Medina F, González-Robles A, et al.The dengue virus non-structural protein 1 (NS1) is secreted efficiently from infected mosquito cells[J]. Virology, 2016, 488:278-287.
[11] Alcalá A C, Hernández-Bravo R, Medina F, et al.The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway[J]. J Gen Virol, 2017, 98(8): 2088-2099.
[12] Akey D L, Brown W C, Jose J, et al.Structure-guided insights on the role of NS1 in flavivirus infection[J]. Bioessays, 2015, 37(5):489-494.
[13] Youn S, Li T, McCune B T, et al. Evidence for a Genetic and Physical Interaction between Nonstructural Proteins NS1 and NS4B That Modulates Replication of West Nile Virus[J]. J Virol, 2012, 86(13): 7360-7371.
[14] Mackenzie J M, Jones M K, Young P R.Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication[J]. Virology, 1996, 220(1): 232-240.
[15] Edeling M A, Diamond M S, Fremont D H.Structural basis of Flavivirus NS1 assembly and antibody recognition[J]. Proc. Natl. Acad. Sci. U.S.A., 2014, 111(11):4285-4290.
[16] Akey D L, Brown W C, Dutta S, et al.Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system[J]. Science, 2014, 343(6173): 881-885.
[17] Gutsche I, Coulibaly F, Voss J E, et al.Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein[J]. Proc Natl Acad Sci USA, 2011, 108(19): 8003-8008.
[18] Fan J, Liu Y, Yuan Z.Critical role of Dengue Virus NS1 protein in viral replication[J]. Virologica Sinica, 2014, 29(3):162-169.
[19] Cervantes-Salazar M, Angel-Ambrocio A H, Soto-Acosta R, et al. Dengue virus NS1 protein interacts with the ribosomal protein RPL18: this interaction is required for viral translation and replication in Huh-7 cells[J]. Virology, 2015, 484:113-126.
[20] Campos R K, Wong B, Xie X, et al.RPLP1 and RPLP2 are essential flavivirus host factors that promote early viral protein accumulation[J]. J Virol, 2017, 91(4): e01706-16.
[21] Kanlaya R, Pattanakitsakul S, Sinchaikul S, et al.Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release[J]. Mol BioSyst, 2010, 6(5):795-806.
[22] Dechtawewat T, Songprakhon P, Limjindaporn T, et al.Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication[J]. Virol J, 2015, 12(1): 14.
[23] Dechtawewat T, Paemanee A, Roytrakul S, et al.Mass spectrometric analysis of host cell proteins interacting with dengue virus nonstructural protein 1 in dengue virus-infected HepG2 cells[J]. Biochim Biophys Acta, 2016, 1864(9): 1270-1280.
[24] Allonso D, Andrade I S, Conde J N, et al.Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity[J]. J Virol, 2015, 89(23): 11871-11883.
[25] Chen J,Ng M M L, Chu J J H. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection[J]. PLOS Pathog, 2015, 11(7): e1005053.
[26] Modhiran N, Watterson D, Blumenthal A, et al.Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6[J]. Immunol. Cell Biol, 2017, 95(5): 491-495.
[27] Glasner D R, Ratnasiri K, Puerta-Guardo H, et al.Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components[J]. PLOS Pathog, 2017, 13(11): e1006673.
[28] Thiemmeca S, Tamdet C, Punyadee N, et al.Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated Neutralization[J]. J Immunol, 2016, 197(10): 4053-4065.
[29] Conde J N, Silva E M, Allonso D, et al.Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins[J]. J Virol, 2016, 90(21): 9570-9581.
[30] Andries A C, Duong V, Ong S, et al.Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens[J]. BMC Infect Dis, 2016, 16(1): 201.
[31] Shukla M K, Singh N, Sharma R K, et al.Utility of dengue NS1 antigen rapid diagnostic test for use in difficult to reach areas and its comparison with dengue NS1 ELISA and qRT-PCR[J]. J Med Virol, 2017, 89(7): 1146-1150.
[32] 中国疾病预防控制中心.登革热实验室检测[EB/OL].2015-06-03[2018-02-02].http://www.chinacdc.cn/jkzt/crb/dgr/zstd/201506/t20150603_115513.htm.
[33] Buonora S N, Santos F B, Daumas R P, et al.Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue 4 cases[J]. BMC Infect Dis, 2017, 17(1): 204.
[34] Mata V E, Passos S R L, Hökerberg Y H M, et al. Accuracy and reliability of an NS1 rapid immunochromatographic test for DENV-1 diagnosis at point of care and in the laboratory[J].BMC Infect Dis, 2017, 7(1): 594.
[35] Wasik D A, Mulchandani A, Yates M V.Point-of-Use Nanobiosensor for Detection of Dengue Virus NS1 Antigen in Adult Aedesaegypti: A Potential Tool for Improved Dengue Surveillance[J]. Anal Chem, 2017, 90(1): 679-684.
[36] Wong W R, Sekaran S D, Adikan F R M, et al. Detection of dengue NS1 antigen using long-range surface plasmon waveguides[J]. Biosens Bioelectron, 2016, 78: 132-139.
[37] LiuY,LiuJ,Cheng G. Vaccines and immunization strategies for dengue prevention[J]. Emerg Microbes Infect, 2016, 5(7): e77.
[38] WHO. 登革热疫苗研究[EB/OL].http://www.who.int/immuniz-ation/research/development/dengue_vaccines/en/. 2017-12-05[<date-in-citation content-type="access-date">2018-2-5</date-in-citation>].
[39] AP NEWS.Philippines:3 deaths may be linked to dengue vaccinations[EB/OL].2018-02-02[2018-2-10]. https://www.apnews.com/876f6e3c7188441e871b4c931d79c759
[40] Amorim J H, Diniz M O, Cariri F A M O, et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant[J]. Vaccine, 2012, 30(5): 837-845.
[41] Srivastava A K, Putnak J R, Warren R L, et al.Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli, are protected against lethal dengue virus infection[J]. Vaccine, 1995, 13(13): 1251-1258.
[42] Costa S M, Freire M S, Alves A M B. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus[J]. Vaccine, 2006, 24(21):4562-4564.
[43] Gonçalves A J S, Oliveira E R A, Costa S M, et al. Cooperation between CD4+ T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen[J]. PLOS Negl. Trop Dis, 2015, 9(12): e0004277.
[44] Lu H, Xu X F, Gao N, et al.Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice[J]. Mol Immunol, 2013, 54(2): 109-114.
[45] Huang S S, Li I H, Hong P, et al.Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus[J]. Int J Nanomed, 2013, 8: 3161-3169.
[46] Miura K, Keister DB, Muratova OV, et al.Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer[J]. Malar J, 2007, 6: 107.
[47] Beatty P R, Puerta-Guardo H, Killingbeck S S, et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination[J]. Sci Transl Med, 2015, 7(304): 304ra141. |
